12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Apr 7 at 12:05 PMADTX-714.00%LNAI+124.00%
09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104prnewswire·Mar 30 at 08:02 AMLABU+339.00%IBBQ+82.00%
Delonix Bioworks clears IND for DX-104 vaccine in China & Australia for MenB; Feb 6, 2026.Unusual Whales·Feb 6 at 06:33 AMIBBQ+82.00%FBT+281.00%
Lunai Bioworks discovers 3 Parkinson's subtypes, targets for $13B market. Exciting progress in precision therapeutics.Unusual Whales·Dec 9, 2025 at 06:46 AMRENB0.00%LNAI+124.00%
Lunai Bioworks shares are trading higher after the company announced the publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines".benzinga_article·Nov 5, 2025 at 09:05 AMLNAI+124.00%RENB0.00%
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy | LNAI Stock NewsStockTitan·Nov 5, 2025 at 08:22 AMLNAI+124.00%RENB0.00%
